Literature DB >> 17388699

Radiosensitization by nitric oxide at low radiation doses.

Peter Wardman1, Kai Rothkamm, Lisa K Folkes, Michael Woodcock, Peter J Johnston.   

Abstract

Nitric oxide was shown to radiosensitize anoxic V79 and CHO hamster cells and MCF7 and UT-SCC-14 human cells, measuring clonogenic survival and/or DNA damage in vitro at low radiation doses (0.1-5 Gy). Radiosensitization was easily detected after 2 Gy in anoxic V79 cells exposed to 40 ppm ( approximately 70 nM) nitric oxide, indicating that nitric oxide is a significantly more efficient radiosensitizer than oxygen. The yield of double-strand breaks (as gamma-H2AX foci) in V79 and MCF7 cells was doubled by irradiation in 1% v/v nitric oxide/N(2), and there was a longer repair time in cells irradiated in nitric oxide than in air or anoxia; single-strand breaks ("comet" assay) also appeared to be enhanced. Potent radiosensitization by nitric oxide is consistent with near diffusion-controlled reaction of nitric oxide with purine and pyrimidine radicals observed by pulse radiolysis, with nitric oxide reacting two to three times faster than oxygen with the 5-hydroxy-uracil-6-yl radical. Stable NO/base adducts were formed with uracil radicals. Effects on the radiosensitivity of cells exposed to as low as 40 ppm v/v nitric oxide after doses of 1-2 Gy suggest that variations in radiosensitivity in individual patients after radiotherapy might include a component reflecting differing levels of nitric oxide in tumors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17388699     DOI: 10.1667/RR0827.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  15 in total

1.  Regulation of Cellular Redox Signaling by Matricellular Proteins in Vascular Biology, Immunology, and Cancer.

Authors:  David D Roberts; Sukhbir Kaur; Jeffrey S Isenberg
Journal:  Antioxid Redox Signal       Date:  2017-09-08       Impact factor: 8.401

2.  NOS Inhibition Modulates Immune Polarization and Improves Radiation-Induced Tumor Growth Delay.

Authors:  Lisa A Ridnour; Robert Y S Cheng; Jonathan M Weiss; Sukhbir Kaur; David R Soto-Pantoja; Debashree Basudhar; Julie L Heinecke; C Andrew Stewart; William DeGraff; Anastasia L Sowers; Angela Thetford; Aparna H Kesarwala; David D Roberts; Howard A Young; James B Mitchell; Giorgio Trinchieri; Robert H Wiltrout; David A Wink
Journal:  Cancer Res       Date:  2015-05-19       Impact factor: 12.701

Review 3.  Novel and emerging targeted-based cancer therapy agents and methods.

Authors:  Mohammad Hojjat-Farsangi
Journal:  Tumour Biol       Date:  2015-02-09

Review 4.  Deoxyribonucleic acid damage-associated biomarkers of ionising radiation: current status and future relevance for radiology and radiotherapy.

Authors:  G Manning; K Rothkamm
Journal:  Br J Radiol       Date:  2013-05-09       Impact factor: 3.039

5.  CpG ODN107 potentiates radiosensitivity of human glioma cells via TLR9-mediated NF-κB activation and NO production.

Authors:  Xiaoli Li; Dan Liu; Xin Liu; Weiwei Jiang; Weiying Zhou; Wei Yan; Yanyan Cen; Bin Li; Guanqun Cao; Guofu Ding; Xueli Pang; Jianguo Sun; Jiang Zheng; Hong Zhou
Journal:  Tumour Biol       Date:  2012-06-28

6.  Contribution of Dual Oxidase 2 (DUOX2) to Hyper-Radiosensitivity in Human Gastric Cancer Cells.

Authors:  Duc M Nguyen; Palak R Parekh; Elizabeth T Chang; Navesh K Sharma; France Carrier
Journal:  Radiat Res       Date:  2015-07-24       Impact factor: 2.841

Review 7.  Newly developed strategies for improving sensitivity to radiation by targeting signal pathways in cancer therapy.

Authors:  Miao Ding; Erlong Zhang; Rong He; Xingyong Wang
Journal:  Cancer Sci       Date:  2013-09-23       Impact factor: 6.716

8.  Targeting tumor hypoxia with the epigenetic anticancer agent, RRx-001: a superagonist of nitric oxide generation.

Authors:  Marcel H Fens; Pedro Cabrales; Jan Scicinski; Sandra K Larkin; Jung H Suh; Frans A Kuypers; Neil Oronsky; Michelle Lybeck; Arnold Oronsky; Bryan Oronsky
Journal:  Med Oncol       Date:  2016-07-04       Impact factor: 3.064

9.  Suberoylanilide hydroxamic acid radiosensitizes tumor hypoxic cells in vitro through the oxidation of nitroxyl to nitric oxide.

Authors:  Yuval Samuni; David A Wink; Murali C Krishna; James B Mitchell; Sara Goldstein
Journal:  Free Radic Biol Med       Date:  2014-05-28       Impact factor: 7.376

10.  The shape of the radiation dose response for DNA double-strand break induction and repair.

Authors:  Stephen Barnard; Simon Bouffler; Kai Rothkamm
Journal:  Genome Integr       Date:  2013-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.